Decrease Metoprolol First for Orthostatic Hypotension
In an older adult with orthostatic hypotension taking both metoprolol and amlodipine, decrease or discontinue the metoprolol (beta-blocker) first, as beta-blockers are more strongly implicated in causing orthostatic hypotension than calcium channel blockers, and emerging evidence suggests that amlodipine may actually reduce orthostatic hypotension prevalence over time.
Rationale Based on Guidelines and Evidence
Beta-Blockers Are More Problematic for Orthostatic Hypotension
The 2024 ESC Guidelines explicitly recommend switching medications that worsen orthostatic hypotension rather than simply de-intensifying therapy 1. Beta-blockers, particularly non-selective agents, are consistently identified as culprit medications for orthostatic hypotension across multiple guidelines 2, 3, 2.
The JNC 7 guidelines specifically note that beta-blockers are among the antihypertensive drugs that can cause orthostatic hypotension, along with alpha-blockers, and that diuretics may further aggravate it 3. The 2005 ACC/AHA Heart Failure guidelines describe how beta-blockers can produce hypotension and dizziness, particularly noting that carvedilol (which also blocks alpha-1 receptors) has vasodilatory side effects 4.
Calcium Channel Blockers May Actually Improve Orthostatic Hypotension
Contrary to traditional concerns, recent evidence suggests calcium channel blockers like amlodipine may be preferable in patients with orthostatic hypotension. A 2018 review specifically states that "angiotensin receptor blockers and calcium channel blockers are preferable antihypertensives for these patients" with orthostatic hypotension 5.
A 2024 meta-analysis found that orthostatic hypotension prevalence actually decreased after antihypertensive treatment initiation or augmentation (risk ratio 0.39), suggesting the risk of inducing orthostatic hypotension may be overestimated 6. While the ALLHAT trial found amlodipine increased fall risk in the first year compared to other agents 7, this was a short-term effect and did not persist long-term.
Practical Clinical Algorithm
Step 1: Confirm Orthostatic Hypotension
- Measure BP after patient lies/sits for 5 minutes, then at 1 and 3 minutes after standing 1
- Document symptoms (dizziness, lightheadedness, near-syncope) that occur specifically upon standing
Step 2: Reduce Metoprolol First
- Decrease metoprolol dose by 50% initially
- If symptoms persist, consider further reduction or discontinuation
- Monitor for rebound tachycardia or angina if metoprolol was prescribed for coronary disease
Step 3: Maintain or Adjust Amlodipine
- Continue amlodipine at current dose unless supine hypertension is absent
- If BP control is inadequate after metoprolol reduction, consider adding an ACE inhibitor or ARB (which are also preferred in orthostatic hypotension) 5
Step 4: Implement Non-Pharmacologic Measures Simultaneously
- Increase fluid intake (2-2.5 liters daily)
- Increase sodium intake (unless contraindicated by heart failure)
- Use compression stockings (waist-high, 15-20 mmHg)
- Educate on rising slowly from supine/seated positions
- Consider abdominal binders 5, 8
Important Caveats
If Metoprolol Is for Heart Failure or Post-MI
If metoprolol was prescribed for heart failure with reduced ejection fraction or post-myocardial infarction (compelling indications), the decision becomes more complex 4, 1. In these cases:
- Reduce dose rather than discontinue entirely
- Consider switching to a different beta-blocker with less orthostatic effect
- Ensure adequate volume status before attributing symptoms to medication
Monitor for Supine Hypertension
Many older adults with orthostatic hypotension have coexisting supine hypertension 2, 3, 2. If present:
- Measure BP both supine and standing at each visit
- Consider short-acting antihypertensives at bedtime only
- Avoid aggressive treatment of supine hypertension that worsens orthostatic symptoms
Medication Review Is Critical
The 2001 European syncope guidelines note that in symptomatic older patients, up to 25% have orthostatic hypotension, and "orthostatic hypotension is predominantly due to culprit medications" 2. Review all medications, not just antihypertensives—look for:
- Alpha-blockers (tamsulosin for BPH)
- Tricyclic antidepressants
- Antiparkinsonian drugs
- Diuretics (which may need dose reduction but not necessarily discontinuation)
The "Brittle Hypertension" Myth
The JNC 7 guidelines warn that "the misperception that many elderly have 'brittle hypertension' has contributed to widespread inadequacy of drug titration and to poor BP control" 3. Don't undertreate hypertension out of excessive caution—uncontrolled hypertension itself can worsen orthostatic hypotension 5, 9.
Target Outcomes
Focus on symptom relief and fall prevention, not specific BP numbers 8. Success means:
- Resolution of orthostatic symptoms (dizziness, near-syncope)
- Maintained BP control (generally <140/90 mmHg, individualized for frailty)
- No increase in falls or syncope
- Preserved quality of life and functional independence
The 2017 ACC/AHA hypertension guidelines emphasize careful BP monitoring when initiating therapy in older adults, noting that "caution is advised in initiating antihypertensive pharmacotherapy with 2 drugs in older patients because hypotension or orthostatic hypotension may develop" 10, 11. This same caution applies when adjusting existing therapy—but the evidence supports preferentially reducing beta-blockers over calcium channel blockers in this scenario.